Concurrent Retinoblastoma 1 ( <i>RB1</i> ) and <i>IKZF1</i> Deletions Have Adverse Outcome in Childhood B‐Cell Acute Lymphoblastic Leukemia (B‐ALL)
The B-ALL patients with concurrent RB1 and IKZF1 deletions had worse outcomes compared to cases without any of these deletions. The RB1 deletion increased the risk of early events in patients with the IKZF1plus profile.
Authors
- D. Pushpam
- S. Bakhshi
- Pranay Sharma (ORCID: https://orcid.org/0009-0007-8027-7913)
- Gadha K. Leons
- Seema Gupta (ORCID: https://orcid.org/0000-0002-3525-6618)
- Ritu Gupta
- Smeeta Gajendra
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- International Journal of Laboratory Hematology
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1111/ijlh.70069
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00